Kontafarma China Holdings Ltd (HK:1312) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Kontafarma China Holdings Limited has announced that its Board of Directors will convene on August 28, 2024, to review and approve the subsidiary’s interim financial results for the first half of the year and to discuss the potential distribution of an interim dividend. The upcoming board meeting is set to shape the company’s financial strategies moving forward. This announcement was made by Chairman Wang Feifei on behalf of the company.
For further insights into HK:1312 stock, check out TipRanks’ Stock Analysis page.